An amendment proposed by Sens. Herb Kohl (D-Wis.) and Dick Durbin (D-Ill.) would prohibit drug companies from mining prescription information for marketing purposes.
Amendment would stop marketing Rx data-mining
The legislation aims to stop “vexatious and harassing sales practices” but it will not regulate the use of data for quality, research and payment purposes, according to language in the amendment. Information could still be used for marketing provided it does not contain individually identifying pieces of data, according to the senators' proposal.
The amendment does not stop the sale of medical records for clinical trials, patient-safety communications or public health issues.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.